stars 1 stars 2 stars 3

We are a pioneering protein degradation and developing transformative medicines to elevate patient health. Our team possesses the scientific knowledge, proprietary technologies, business acumen and risk tolerance required to unlock this pioneering field of science and ultimately deliver disease-modifying therapies for patients. We harness the human body’s natural protein degradation machinery to discover and develop transformative new medicines to treat patients with life-altering diseases. With our approach, we are able to pursue previously undruggable disease targets and pioneer this expansive field with speed and scale. We integrate extensive medicinal chemistry and biology intuition with deep, proprietary artificial intelligence capabilities – resulting in a robust pipeline that spans a range of therapeutic areas and novel molecular targets.

View Top Employees from Proteovant Therapeutics
Website https://www.skbp.com/eng.do
Employees 35 (34 on RocketReach)
Founded 2021
Industry Biotechnology

Proteovant Therapeutics Questions

Ruby Holder is the Chief Strategy Officer of Proteovant Therapeutics.

34 people are employed at Proteovant Therapeutics.

Proteovant Therapeutics is based in Philadelphia, Pennsylvania.

Top Proteovant Therapeutics Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users